About the Company
electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ECOR News
electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript
March 13, 2024 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.55. ECOR ...
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS ...
electroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...
Q4 2023 electroCore, Inc. Earnings Call
Hello, and welcome to the electroCore Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast. (Operator Instructions) At this time, I'd like to turn the call over to Dan Goldberger, ...
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
ROCKAWAY, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine and wellness company, today ...
electroCore to Participate in Upcoming Investor Conferences
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend ...
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
Hello, and welcome to the electroCore Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
electroCore, Inc.: electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY, N.J.
Q4 2023 electroCore, Inc. Earnings Call
Q4 2023 electroCore, Inc. Earnings Call ...
Loading the latest forecasts...